Glucotrack Completes Second Long-Term Preclinical Study For Its Continuous Blood Glucose Monitor, Demonstrating Mean Absolute Relative Difference Of 4.7% At Day 90
Glucotrack Completes Second Long-Term Preclinical Study For Its Continuous Blood Glucose Monitor, Demonstrating Mean Absolute Relative Difference Of 4.7% At Day 90
Glucotrack完成其連續血糖監測器的第二次長期臨牀前研究，展示出在第90天時的平均絕對相對差異為4.7%。
Glucotrack Completes Second Long-Term Preclinical Study For Its Continuous Blood Glucose Monitor, Demonstrating Mean Absolute Relative Difference Of 4.7% At Day 90
Glucotrack完成了第二個長期臨床前研究，針對其持續血糖監測器進行研究，證明在第90天的平均絕對相對差爲4.7%。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。